Lexaria Bioscience Corp. - stock earnings
LEXX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -1.3 million USD | 35015 USD |
| 2022Q4 | -1.8 million USD | 101476 USD |
| 2022Q3 | -1.5 million USD | 111150 USD |
| 2022Q2 | -2.4 million USD | 99717 USD |
| 2022Q1 | -1.4 million USD | 30650 USD |
| 2021Q4 | -2.0 million USD | 13880 USD |
| 2021Q3 | -1.2 million USD | 31021 USD |
| 2021Q2 | -2.6 million USD | 204055 USD |
| 2021Q1 | 404111 USD | 192006 USD |
| 2020Q4 | -696028 USD | 295656 USD |
| 2020Q3 | -714958 USD | 133739 USD |
| 2020Q2 | -1.4 million USD | 81423 USD |
LEXX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -6.7 million USD | 226208 USD |
| 2022 | -7.3 million USD | 255397 USD |
| 2021 | -2.5 million USD | 722738 USD |
| 2020 | -4.0 million USD | 384543 USD |
| 2019 | -4.2 million USD | 222610 USD |
| 2018 | -6.6 million USD | 433287 USD |
| 2017 | -1.9 million USD | 63639 USD |
| 2016 | -1.2 million USD | 40718 USD |
| 2015 | -1.8 million USD | 14702 USD |
| 2014 | ? USD | 1.1 million USD |
| 2013 | -343551 USD | 1.1 million USD |
| 2012 | -251508 USD | 1.4 million USD |
| 2011 | -538226 USD | 1.1 million USD |
| 2010 | -552462 USD | 362471 USD |
| 2009 | -753573 USD | 421955 USD |
| 2008 | -978490 USD | 900789 USD |
| 2007 | -1.1 million USD | 253148 USD |
| 2006 | -508257 USD | 20307 USD |
| 2005 | -75722 USD | ? USD |
LEXX
Price: $3.13
52 week price:
Earnings Per Share: -0.84 USD
P/E Ratio: -2.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 7400
Market Capitalization: 30.2 million